Drug shortages derail CCGs’ budgetsBMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k331 (Published 24 January 2018) Cite this as: BMJ 2018;360:k331
- Gareth Iacobucci
- The BMJ
Financial plans of clinical commissioning groups are being derailed by emergency hikes in prices of generic drugs, which have led to soaring costs, The BMJ has learnt.
Last month The BMJ reported that ongoing shortages of generic drugs cost the NHS £38m in November 2017,1 as the government agreed more emergency price increases to boost stocks.
An examination of board papers by The BMJ has found that many CCGs are reporting significant risks to their financial plans as a result of the price increases. Included are some of the most financially stricken CCGs that were ordered by NHS England and NHS Improvement to draw up radical cost savings plans this year as …